Jump Financial, LLC Collegium Pharmaceutical, Inc Transaction History

Jump Financial, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.4 - $39.07 $1.41 Million - $1.75 Million	-44,776 Closed	0 $0
Q2 2024 Aug 14, 2024	SELL	$31.36 - $39.99 $660,567 - $842,349	-21,064 Reduced 31.99%	44,776 $1.44 Million
Q1 2024 May 13, 2024	BUY	$31.23 - $40.91 $860,074 - $1.13 Million	27,540 Added 71.91%	65,840 $2.56 Million
Q4 2023 Oct 21, 2024	SELL	$21.16 - $30.8 $112,063 - $163,116	-5,296 Reduced 12.15%	38,300 $1.18 Million
Q4 2023 Feb 07, 2024	BUY	$21.16 - $30.8 $810,428 - $1.18 Million	38,300 New	38,300 $1.18 Million
Q2 2023 Oct 21, 2024	SELL	$21.06 - $24.0 $240,189 - $273,720	-11,405 Reduced 20.74%	43,596 $936,000
Q2 2023 Aug 07, 2023	SELL	$21.06 - $24.0 $240,189 - $273,720	-11,405 Reduced 20.74%	43,596 $936,000
Q1 2023 Oct 21, 2024	BUY	$23.0 - $29.88 $235,175 - $305,523	10,225 Added 22.84%	55,001 $1.32 Million
Q1 2023 May 03, 2023	BUY	$23.0 - $29.88 $1.27 Million - $1.64 Million	55,001 New	55,001 $1.32 Million
Q2 2021 Aug 13, 2021	SELL	$21.74 - $25.28 $322,882 - $375,458	-14,852 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $285,901 - $387,637	14,852 New	14,852 $352,000

255

38.6M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.01B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.